Background Severe intracranial atherosclerotic stenosis (ICAS) is a major cause of stroke.
Although percutaneous transluminal angioplasty and stenting (PTAS) treatment methods …

Objectives Severe symptomatic intracranial stenosis is an important cause of stroke.
Intracranial stenting is alternatively applied to treat intracranial atherosclerotic disease …

ABSTRACT OBJECTIVE The results of prematurely terminated stenting and aggressive
medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) …

Background and purpose Analysis of procedural results and 30-day outcome after
intracranial angioplasty and stenting (ICAS) with the balloon-expandable Pharos Vitesse …

Importance Prior randomized trials have generally shown harm or no benefit of stenting
added to medical therapy for patients with symptomatic severe intracranial atherosclerotic …

BACKGROUND: Patients with recent transient ischemic attack (TIA) or stroke caused by
70% to 99% stenosis of a major intracranial artery are at high risk of recurrent stroke on …

Patients with symptomatic intracranial stenosis are at high risk of subsequent stroke despite
the use of antithrombotic agents or surgical management. Although endovascular therapy …

Background Recently, several randomized controlled trials (RCTs) of stenting plus medical
therapy versus medical therapy alone have been successfully conducted for the treatment of …

BACKGROUND AND PURPOSE: On the basis of the high 1-month stroke and/or death
(14.7%) rates associated with stent placement in the Stenting versus Aggressive Medical …

Background and aims Comparing safety and technical success of balloon-expandable
stents and self-expanding stents for intracranial angioplasty and stenting in medically …